// App-Quantinova.ai

EP660 : EUTOS EXPERIENCE OF STANDARDISATION OF MOLECULAR MONITORING FOR CML (2016 – 2020). USE OF SECONDARY BCR-ABL1 REFERENCE MATERIALS FOR CONVERSION FACTOR VALIDATION AND ASSESSMENT OF MR4.5 DETECTION

Researchers

Presenter

  • Helen White

Principal Investigators

  • Matthew Salmon

  • Katerina Machova Polakova

  • Susanne Saussele

  • Andreas Hochhaus

  • Nicholas Cross

Medical Centers

  • Department of Hematology and Oncology, MHH, Hannover, Germany

  • University of Southampton, United Kingdom.

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • University of Jena,Jena,Germany

Locations

  • Germany

  • United Kingdom

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved